Edition:
India

KemPharm Inc (KMPH.OQ)

KMPH.OQ on NASDAQ Stock Exchange Global Market

5.70USD
20 Feb 2018
Change (% chg)

$-0.10 (-1.72%)
Prev Close
$5.80
Open
$6.00
Day's High
$6.00
Day's Low
$5.53
Volume
29,475
Avg. Vol
10,670
52-wk High
$6.75
52-wk Low
$2.45

Select another date:

Fri, Nov 10 2017

BRIEF-KemPharm posts Q3 loss per share $0.68

* KemPharm reports third quarter 2017 results and provides corporate update

BRIEF-KemPharm receives USAN approval for “asalhydromorphone” as nonproprietary name for novel prodrug candidate, KP511

* KemPharm Inc receives USAN approval for “asalhydromorphone” as nonproprietary name for novel prodrug candidate, KP511 Source text for Eikon: Further company coverage:

BRIEF-KemPharm says KP484 allowed to proceed to clinical studies​

* kempharm’s kp484 for the treatment of adhd, an investigational prodrug of methylphenidate, allowed to proceed to clinical studies

BRIEF-KemPharm files IND application for KP484 for the treatment of ADHD

* KemPharm files IND for KP484 for the treatment of ADHD, an investigational prodrug of methylphenidate

Select another date: